Neurodegenerative diseases and Withania somnifera (L.): An update
- PMID: 32240781
- DOI: 10.1016/j.jep.2020.112769
Neurodegenerative diseases and Withania somnifera (L.): An update
Abstract
Ethnopharmacological relevance: Withania somnifera (L.) Dunal also known as 'Ashwaghanda' in Sanskrit and as 'Indian Winter Cherry' in english. is an important medicinal herb in India. It is widely used in Indian systems of medicine as an adaptogen, nerve tonic, anti-stress, memory enhancer and against cognitive deficits, insomnia, anxiety, infectious diseases, infertility, rheumatoid arthritis and gout over thousands of years. Its formulations are mainly used in Unani and Ayurvedic system of medicine. It is a remarkable centuries old herbal Rasayana used to treat neuronal ailments and is known as ''Sattvic Kapha Rasayana.
Aim of the study: To review neuroprotective properties of Withania somnifera (L.)extract as well as its active constituents in neurodegenerative diseases and other neurological ailments.
Materials and methods: The sources of information used in present article include Indian system of Medicine reports on the use of natural products, Medicinal books, research articles and scientific databases like PubMed, Google Scholar, Web of Science, Science-Direct, SciFinder, ACS Publications and Wiley Online Library.
Results: Research reports based largely on preclinical studies as well as few clinical trials have highlighted the neuroprotective role of Ashwagandha against many neurodegenerative diseases including Alzheimer's, Huntington's and Parkinson's disease. The protective effects of Ashwagandha were accomplished by restoring mitochondrial and endothelial function, mitigation of apoptosis, inflammation and oxidative stress mechanisms.
Conclusion: In this review, we recapitulated neuroprotective properties of Ashwagandha extracts and/or its major constituents and discussed their mechanisms of action and potential therapeutic applications. The pre-clinical as well as clinical studies suggest the use of Withania somnifera (L.) against neurodegenerative disease. However, extensive studies are warranted to validate the use of extract or its single constituents for its clinical use.
Keywords: Alzheimer's disease; Anti-inflammatory; Anti-stress; Huntington's; Nerve tonic; Neuroprotection; Parkinson's disease; Stroke; Withania somnifera; Withanolide-A; Withanone.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest Authors do not have any conflict of interest
Similar articles
-
Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.J Ethnopharmacol. 2021 Jan 10;264:113157. doi: 10.1016/j.jep.2020.113157. Epub 2020 Aug 9. J Ethnopharmacol. 2021. PMID: 32783987 Review.
-
Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.Cent Nerv Syst Agents Med Chem. 2010 Sep 1;10(3):238-46. doi: 10.2174/1871524911006030238. Cent Nerv Syst Agents Med Chem. 2010. PMID: 20528765 Review.
-
Therapeutic Evaluation of Unani Medicine, Including Single Drugs and Polyherbal Formulations with Special Reference to Neurodegenerative Disorders.Altern Ther Health Med. 2024 Sep;30(9):54-64. Altern Ther Health Med. 2024. PMID: 39212516 Review.
-
Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.J Ethnopharmacol. 2021 Apr 24;270:113704. doi: 10.1016/j.jep.2020.113704. Epub 2020 Dec 25. J Ethnopharmacol. 2021. PMID: 33359918 Review.
-
In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.Phytother Res. 2010 Oct;24(10):1567-74. doi: 10.1002/ptr.3261. Phytother Res. 2010. PMID: 20680931
Cited by
-
Molecular Modeling Targeting Transmembrane Serine Protease 2 (TMPRSS2) as an Alternative Drug Target Against Coronaviruses.Curr Drug Targets. 2022;23(3):240-259. doi: 10.2174/1389450122666210809090909. Curr Drug Targets. 2022. PMID: 34370633 Review.
-
An updated review on phytochemistry and molecular targets of Withania somnifera (L.) Dunal (Ashwagandha).Front Pharmacol. 2023 Mar 29;14:1049334. doi: 10.3389/fphar.2023.1049334. eCollection 2023. Front Pharmacol. 2023. PMID: 37063285 Free PMC article. Review.
-
Withania somnifera Extracts Promote Resilience against Age-Related and Stress-Induced Behavioral Phenotypes in Drosophila melanogaster; a Possible Role of Other Compounds besides Withanolides.Nutrients. 2022 Sep 22;14(19):3923. doi: 10.3390/nu14193923. Nutrients. 2022. PMID: 36235577 Free PMC article.
-
Withania somnifera and Centella asiatica Extracts Ameliorate Behavioral Deficits in an In Vivo Drosophila melanogaster Model of Oxidative Stress.Antioxidants (Basel). 2022 Jan 6;11(1):121. doi: 10.3390/antiox11010121. Antioxidants (Basel). 2022. PMID: 35052625 Free PMC article.
-
Phytochemicals of Withania somnifera as a Future Promising Drug against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery.Microorganisms. 2023 Apr 12;11(4):1000. doi: 10.3390/microorganisms11041000. Microorganisms. 2023. PMID: 37110423 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials